Evidence map›Paper›PMID 39591141›Full record

ReviewVaccines2024

Evaluating the Quality of Studies Assessing COVID-19 Vaccine Neutralizing Antibody Immunogenicity.

Maeva Katzmarzyk, Robert Naughton, Ioannis Sitaras, Henning Jacobsen, Melissa M Higdon, Maria Deloria Knoll

Abstract readReview
In one paragraph

Review in Vaccines, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Maeva KatzmarzykDepartment of Viral Immunology, Helmholtz Center for Infection Research, 38124 Braunschweig, Germany.ORCID 0009-0001-3255-4150
Robert NaughtonIndependent Researcher, London SW16 2TS, UK.ORCID 0000-0002-6167-0687
Ioannis SitarasW. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.ORCID 0000-0003-0161-8024
Henning JacobsenDepartment of Viral Immunology, Helmholtz Center for Infection Research, 38124 Braunschweig, Germany.
Melissa M HigdonInternational Vaccine Access Center, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.ORCID 0000-0002-1932-9442
Maria Deloria KnollInternational Vaccine Access Center, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.ORCID 0000-0001-9041-2671

Funding

Coalition for Epidemic Preparedness Innovations 138587
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVD-19neutralizing antibodiesreliabilityreporting qualitySARS-CoV-2

Identifiers

PMID39591141
PMCPMC11598362

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.